Health issues related to obesity can take many different forms. Obese people are more likely to have nonalcoholic steatohepatitis (NASH), a kind of fatty liver disease that can lead to cancer. <br /><br />The lack of appropriate and effective techniques to separate and characterise hepatic stellate cells (HSCs), which have been shown to play a key role in the advancement of liver fibrosis and liver cancer in NASH patients, has contributed to the lack of treatment for NASH. <br /><br />With their novel method of performing cold enzymatic perfusion to separate HSCs from both murine and human fatty liver-associated malignancies, researchers from Osaka Metropolitan University made a significant advancement in their quest.<br /><br /> Cellular and Molecular Gastroenterology and Hepatology published this research.
